While advances in regenerative medicine and vascular tissue engineering have been substantial in recent years, important stumbling blocks remain. In particular, the limited life span of differentiated cells that are harvested from elderly human donors is an important limitation in many areas of regenerative medicine. Recently, a mutant of the human telomerase reverse transcriptase enzyme (TERT) was described, which is highly processive and elongates telomeres more rapidly than conventional telomerase. This mutant, called pot1-TERT, is a chimeric fusion between the DNA binding protein pot1 and TERT. Because pot1-TERT is highly processive, it is possible that transient delivery of this transgene to cells that are utilized in regenerative medicine applications may elongate telomeres and extend cellular life span while avoiding risks that are associated with retroviral or lentiviral vectors. In the present study, adenoviral delivery of pot1-TERT resulted in transient reconstitution of telomerase activity in human smooth muscle cells, as demonstrated by telomeric repeat amplification protocol (TRAP). In addition, human engineered vessels that were cultured using pot1-TERT-expressing cells had greater collagen content and somewhat better performance in vivo than control grafts. Hence, transient delivery of pot1-TERT to elderly human cells may be useful for increasing cellular life span and improving the functional characteristics of resultant tissue-engineered constructs.
INTRODUCTION
elderly or suffer from vascular disease, meaning that autologous cell sources are frequently inadequate due to shortened replicative life span (16). In order to create an Vascular disease is a pressing problem in today's society, creating a strong demand for small-diameter vasengineered vessel, extensive cellular expansion is required in the laboratory, and the cells from elderly pacular bypass conduits. Autologous venous grafts are often used, although approximately 12% of all patients tients are often not capable of sufficient expansion to allow growth of a functional vessel (15) . In order to cirsuffering from coronary artery disease are ineligible for current methods of surgical intervention (18, 20) . There cumvent this problem, we and others have utilized the reverse transcriptase telomerase to extend telomeres and is additional need for small-diameter vascular grafts for patients requiring dialysis access and those suffering cellular replicative capacity (4, 21, 25) . Telomerase consists of an RNA primer subunit and from peripheral vascular disease. This work is targeted at the eventual development of engineered small-diamean enzymatic subunit. Telomerase reverse transcriptase (TERT) is the enzymatic component of human telometer vascular grafts, using a patient's own cells as the source.
rase, which is coupled with an RNA primer in vivo to provide telomere-extending capability. Although the Previous work from our laboratory has demonstrated the feasibility of growing engineered vascular grafts us-RNA component of telomerase is expressed in most cells, TERT is only expressed in gametes, cells of the ing human cell sources (15) . However, patients who are in need of a replacement vascular conduit tend to be fetus, and in adult stem cells, although some cell types can express low levels of telomerase activity during life. from the pot1-TERT cell population performed better than control vessels. Together, these results suggest that Studies in our laboratory have shown that introduction of ectopic TERT in vascular cells from elderly donors transient activation of telomerase may be promising for tissue engineering applications using cells from an elexpands cellular life span and allows for the culture of engineered vessels from patients up to 74 years old (21).
derly donor. This extension of telomere length, and consequent ex-MATERIALS AND METHODS tension of replicative life span, was effected over many
Plasmids, Viruses population doublings, necessitating a retroviral vector to confer permanent TERT expression. However, there are
The pot1-TERT fusion construct was engineered into concerns regarding the use of TERT and retroviruses in the pBabe-hygro plasmid. A pBabe-GFP-hygro plasmid, cells that are destined for human implantation. Although with green fluorescent protein (GFP) in place of pot1-telomerase is not an oncogene, it is activated in many TERT, was used as a vector control. Replication incomtypes of cancer (24) and concern exists that TERT actipetent adenoviral vectors expressing the pot1-TERT vation could increase the probability of carcinogenic transgene were generated using the pAdeasy system actransformation in an implanted tissue. In addition, retrocording to the supplier's directions (Stratagene). Briefly, viral delivery of TERT or any other gene may increase the pot1-TERT coding regions were removed from the the risk of cancer, in light of previous results of gene pot1-TERT pBabe plasmid using the NheI and SalI retherapy trials for severe combined immunodeficiency (8) .
striction sites. This fragment was cloned into the pCMV The DNA-binding protein protection of telomeres shuttle plasmid between the BglII and SalI restriction (pot1) is the principle single-stranded DNA binding prosites. This CMV-pot1-TERT shuttle was recombined tein at the telomere (3, 5) . Together with a host of other with the AdEasy vector in BJ5183 E. coli cells to generproteins, pot1 forms the complex termed shelterin (17) , ate the pot1-TERT Adeasy vector, which was transwhich regulates telomerase activity at the telomere and duced into HEK 293 cells and successively amplified. which protects the single-stranded telomere end from Recombinant pot1-TERT adenoviral vector was purified DNA repair mechanisms (12, 13) . Earlier work has via ultracentrifugation on two successive cesium chloshown that fusion of pot1 to TERT allows the rapid exride gradients. Control GFP adenovirus was provided by tension of telomeres (1, 5) . The ability of the pot1-TERT Dawn Bowles. Plasmids were verified by PCR. Plasmid fusion protein to rapidly lengthen telomeres gives rise construction is demonstrated in Figure 1 . to the idea that this fusion protein could be used to tranCell Isolation siently and rapidly lengthen telomeres in cells that were destined for cellular therapy. In other words, we hypothHuman aortic smooth muscle cells (SMC) were isoesized that transient ectopic expression of pot1-hTERT lated from a deceased 41-year-old male using standard in elderly cells would lengthen telomeres sufficiently to explant techniques and with approval from the Yale increase cellular life span and render these cells useful University Human Investigation Committee. Isolated for cellular therapies. In addition, avoidance of any retcells were expanded in DMEM containing 10% fetal roviral vector, and strictly transient delivery of the transbovine serum (Hyclone), 1% penicillin/streptomycin gene, may enhance the safety of cell life span extension (Sigma), and SmGM-2 aliquots (Lonza, Hopkinton, for regenerative medicine.
MA; the aliquots of antibiotic and serum from the In order to investigate this hypothesis with regard to SmGM-2 were not used). SMC were grown in humidithe development of an engineered vessel, we transduced fied incubators at 37°C and 5% CO 2 . Cells were either human smooth muscle cells from a single adult human cultured without viral transduction or were transduced donor with a pot1-TERT-encoding adenovirus. The cells for 48 h with one of two adenoviruses: the pot1-TERTwere studied in vitro for telomerase activity and for celcontaining adenovirus, or a green fluorescent protein lular replicative potential. Subsequently, we grew small-(GFP) control adenovirus. A population doubling (PD) diameter vessels using both the pot1-TERT cells and value of 0 was arbitrarily assigned to the first confluent control cells in specially designed bioreactors. The vesplate after infection. sels were assayed for collagen content, apoptosis, and Engineered Vessel Culture cellular proliferation. A small number of vessels were implanted into nude rats as abdominal aortic interposiBlood vessel bioreactors, pulsatile flow systems, and polyglycolic acid (PGA) meshes were prepared as detional grafts. We found increased life span and telomerase activity in vitro and increased turnover in vessel scribed previously (19). PGA mesh was prepared around 1 mm outer diameter (OD) silicone tubing (St. Gobain culture of the pot1-TERT-transduced cells, as well as increased collagen deposition, compared to control and Performance Plastics, Beaverton, MI) and seeded with either uninfected SMC, SMC infected with an adenovi-GFP-transduced cells. In addition, implanted vessels rus encoding pot1-TERT, or SMC infected with a vector (Sigma) and assayed for telomerase activity using the TRAPeze Telomerase Detection Kit (Chemicon, Billercontrol adenovirus encoding GFP. SMC were seeded onto the PGA mesh at 5 × 10 5 cells per mesh, and bioreica, MA) according to the manufacturer's instructions. actors were filled with culture medium, consisting of DMEM (Gibco) with 20% fetal bovine serum (Hyclone);
Collagen Analysis 50 mg/L of ascorbic acid, proline, and glycine (Sigma);
Collagen was quantified using a colorimetric assay to 20 mg/L alanine; 0.75 µg/L copper sulfate (Sigma); 10 detect OH-proline using a modified Grant's method (7). mM HEPES (JRH Biosciences); and 10 ng/ml of basic Vessel samples were weighed and lyophilized, then infibroblast growth factor and platelet-derived growth faccubated in papain (140 µg/ml) at 60°C overnight. Pator B (Sigma). Engineered vessels were grown with pulpain-digested samples were incubated in 6 N HCl at sation at ϳ165 bpm and ϳ1% radial distension for 8 115°C for 18 h, neutralized, oxidized with chloramineweeks in humidified incubators at 37°C and 5% CO 2 .
T, and reacted with p-dimethylaminobenzaldehyde. Absorbance was measured at a wavelength of 550 nm and Vessel Implantation a 1:10 w/w ratio of hydroxyproline to collagen was used All animal experiments were reviewed and approved to calculate the collagen content of the vessels. Lyophiby the Institutional Animal Care and Use Committee at lized vessel weights were used to determine percentage Yale University. Male 3-month-old nude rats (CrI:NIHcollagen content. rnu) were purchased from Charles River Laboratories (Wilmington, MA). After induction of anesthesia, a midImmunohistochemistry line laparotomy was performed and the visceral organs retracted to expose the abdominal aorta. The engineered Vessel samples from before and after implantation were fixed in formalin, dehydrated, and embedded in vessels were implanted as aortic interpositional grafts using 10-0 prolene suture and standard operative techparaffin. Thin (5 µm) sections were deparaffinized and immunostained to assay for dividing and apoptotic cell niques, and then the abdomen was closed. A single intraoperative dose of heparin was administered at 70 U/kg nuclei. Cell proliferation was assessed via staining for proliferating cell nuclear antigen (PCNA) (Zymed, San for anticoagulation. Necropsy was performed to retrieve the grafts for histological analysis.
Francisco, CA), and apoptotic nuclei were detected with terminal dUTP nick-end labeling (TUNEL) stain (CalbiTelomerase Activity ochem, San Diego, CA). Sections were counterstained with hematoxylin or methyl green, and positive and negLysates from the SMC were prepared in RIPA buffer (Boston Bioproducts) with added protease inhibitors ative nuclei were counted by a blinded researcher. Histo-logical stains for H&E were performed by the Yale University Research Histology facility.
RESULTS

Pot1-TERT SMC Demonstrate Increased Telomerase Activity and Increased Cellular Replication
Control human SMC, isolated from adult proximal aorta, were infected with GFP-containing or pot1-TERT-containing adenoviral constructs (Fig. 1) . Cultures were split at passage 5, with some being used for in vitro analysis and others being used to grow engineered vessels.
Telomerase activity was assessed using telomere repeat amplification protocol (TRAP) assay, shown in Figure 2A . The TRAP assay confirms the presence of functional telomerase activity in cell lysates. Functional telomerase results in 6 bp laddering of the telomeric TTAGGG repeat. Absence of the laddering after heat inactivation of telomerase confirms that the 6-bp laddering is specific for telomerase activity and does not represent PCR artifact. The TRAP assay showed significant telomerase activity only in positive control cells (provided with the kit), as well as cells that were transduced with adenoviral pot1-TERT at passage 5 after transduction. The same pot1-TERT-infected cells at higher passage (passage 8) did not show telomerase activity on TRAP assay, implying that the vector and transgene were lost during serial passage. Cells that were transduced with GFP-containing adenovirus, and cells that were untransduced, did not show demonstrable telomerase activity (Fig. 2A) .
Growth curves were obtained after transduction to examine the cellular life span for pot1-TERT-transduced and control cells (Fig. 2B) . Growth of control cells reached a plateau by approximately 12 population dou- this point. These results confirm the observations seen on TRAP assay regarding telomerase activity, and imply cells. After 8 weeks of culture, resultant vessels were that telomerase activity in pot1-TERT cells resulted in assessed for cell proliferation and apoptosis, collagen some extension of replicative life span. content, and histologic appearance (Fig. 3) . Due to limiPot1-TERT SMC Demonstrate Increased Cellular tations in total cell number available from a single huTurnover in an Engineered Vessel man donor, we were able to culture two vessels each from pot1-TERT cells, GFP-transduced cells, and conSmall-diameter (1 mm) vessels were grown in vitro in specially designed bioreactors, using the pot1-TERT trol (untransduced) smooth muscle cells. Each vessel had a diameter of 1.0 mm and a length of 8 cm. Vessels cells, GFP-transduced cells, or nontransduced control grown from the untransduced control, GFP-transduced, quantify the PCNA and TUNEL results, we stained several sections of each vessel and counted positive and and pot1-TERT-transduced cells had similar gross appearances on histology (H&E staining) (Fig. 3) .
negative nuclei as a percentage of total (Fig. 5) . Pot1-TERT vessels demonstrated 20% PCNA + nuclei and Cell proliferation for each of the six vessels was assessed using staining for PCNA, and apoptosis was as-21% TUNEL + nuclei, versus approximately 5% PCNA + and 3% TUNEL + nuclei in the control SMC vessels. sessed using TUNEL. The two vessels grown from pot1-TERT cells demonstrate many proliferating nuclei as Data from GFP-transduced vessels were similar to the control SMC vessels. The increased cellular proliferawell as apoptotic cell nuclei (Fig. 4) . By contrast, the vessels cultured from control SMC and the GFP-transtion in vessels cultured from pot1-TERT cells likely reflects increased life span conferred by the transient actiduced vessels showed fewer proliferating and apoptotic nuclei on multiple histological sections. In order to vation of pot1-TERT, consistent with TRAP assay grafts (Fig. 7 ). There were three experimental groups, with n = 4 animals in each group: control SMC, GFPtransduced SMC, and pot1-TERT SMC. Because each vessel that was cultured was 8 cm in length, and because only 1 cm of length is needed for aortic interposition grafting, we were able to implant multiple aortic grafts from a single engineered vessel. Animals that were implanted with control vessels, using either nontransduced or GFP-transduced cells, all suffered graft failure from rupture or thrombosis and subsequent death within 2-3 h, with most failing immediately after implantation. This was a reflection of the low collagen content and resultant poor mechanical properties of the control SMC and GFP-transduced engineered tissues. In the pot1-TERT group, two animals survived for 1 day and one animal survived for 3 days postimplant. The fourth graft in the pot1-TERT group failed from immediate rupture. Although preliminary, these findings suggest that coupled findings of increased cellular proliferation as well as apoptosis indicate a cell population undergoing active remodeling, consistent with increased collagen results. The results of the TUNEL staining may be indicative of increased cellular turnover-proliferation as deposition and subsequent superior vessel performance upon implantation. Thus, although preliminary and of well as cell death and scavenging-in vessels cultured with telomerase-activated cells.
Pot1-TERT SMC Produce More Collagen Than Control Cells in an Engineered Vessel
Vessels grown using pot1-TERT SMC produced approximately double the collagen compared to vessels grown from control cells or GFP-transduced SMC (Fig.  6 ). This is in contrast to previous studies, which showed collagen production to be unaffected in TERT-expressing cells compared to control cells (15) . This difference may arise from a difference in cell source. Previous work employed cells from 2-year-old donor aorta, whereas this study used cells from the aorta of an adult donor. It is possible that extension of life span translates to maintained collagen production during tissue regeneration from older human cells. This increase in collagen production resulted in an apparent increase in mechanical characteristics. We tested the rupture strength of one pot1-TERT vessel and one vessel grown from control 
Implantation of Engineered Vessels
Control and GFP-Adeno data, while two vessels were analyzed After 8 weeks of in vitro culture, engineered vessels for pot1-TERT data. No significance is indicated because vessel number is limited. Error bars represent SEMs.
were implanted into nude rats as aortic interpositional limited scope, the findings here indicate that transient 10 −3 to 10 −5 per infected cell (9) . In conjunction with the fact that these cells were not grown under selection, it telomerase activation via pot1-TERT aids in the growth of engineered vessels.
is highly unlikely that the transgene remains in high passage cells, which is consistent with the TRAP data. In DISCUSSION addition, because of the lack of drug selection pressure during bioreactor vessel culture, cells that had lost adeTelomerase activation is necessary to extend cellular life span and allow the growth of engineered vessels noviral expression were able to continue replicating along with the cells that still retained adenovirus. from adult smooth muscle cell populations (21). However, telomerase is upregulated in the vast majority of Findings from the TRAP assay are consistent with growth curves, which demonstrate senescence of the all human malignancies (24). As a result, any tissueengineered product that contains cells with activated control and GFP-transduced cell populations approximately 12 population doublings after transduction, but telomerase would see challenges to attaining clinical acceptance. In order to overcome these concerns, adenoviwhich show extended replication of the pot1-TERT cultures. The transient telomerase activity in the pot1-ral delivery of the fusion protein pot1-TERT was used in these experiments. This approach provides two ad-TERT cells was able to extend the cellular life span of this population as expected. The dual advantage of tranvantages. First, the pot1-TERT fusion protein provides highly efficient telomerase activity, by facilitating recruitsient delivery and a highly processive telomerase mutant opens the door to the creation of engineered tissues from ment of telomerase to the telomere via the DNA-binding protein pot1 (1) . Second, by delivering pot1-TERT via adult cell populations in a safe, efficacious manner. It would be insightful for future studies to explore this apadenovirus, we were able to activate telomerase only transiently. TRAP analysis confirms that telomerase acproach using cells from older donors, who would better represent the target patient population. tivity is present in the pot1-TERT cells, but that it declines with higher passages. This decline of telomerase From the small number of vessels that could be cultured from a single donor, we found evidence of inactivity with passage is expected and desirable, because the adenovirus is diluted out with cell divisions and becreased collagen deposition, improved mechanics, and some evidence of improved in vivo function in vessels cause our goal is to have a final cellular product that is devoid of the transgene. While PCR would be required cultured from pot1-TERT-expressing cells. However, the wall strengths of all of the vessels were not sufficient to be absolutely certain the transgene is absent in the cells, adenoviral vectors generally do not to integrate to reliably support long-term in vivo function, meaning that greater improvement in wall thickness, stiffness, and remain episomal, with an integration rate of only and suture retention strength are all still required. Furobserved increased collagen deposition. In analogy to an in vivo example of positive vessel remodeling, Wang ther improvements in matrix deposition, and hence vessel mechanics, may be obtained from optimization of the and coworkers found increased collagen deposition as well as increased apoptosis in thoracic aortic dissection culture medium to support collagen synthesis from human cells. Such culture medium optimization, examin- (26) . Taken together, the increased proliferation, increased apoptosis, and increased collagen deposition ing serum concentration and species, as well as growth factor supplementation, is an ongoing effort.
seen in the pot1-TERT vessels are suggestive of a vessel that is actively remodeling. The ability of the pot1-In this study, we found increased collagen deposition by pot1-TERT cells, presumably due to their increased TERT cells to turn over more rapidly and deposit more collagen suggests that transient telomerase activation is life span from the transient telomerase activation. This correlates with improved mechanics in the pot1-TERT a promising approach in the development of an engineered vessel that is more able to adapt to fulfill the vessels, and is consistent with previous findings from our laboratory, wherein we used retroviral-mediated dedemands of in vivo implantation. livery of telomerase (hTERT) (21). In our previous re-CONCLUSION ports, we were not able to grow tissues from older (i.e., >60 years old) donors using control cells (we were only
We have grown small-diameter tissue-engineered successful in growing vessels from older donors using vessels using human smooth muscle cells from an adult hTERT cells), and this skewed our comparisons of donor that were transduced with an adenoviral construct pooled vessels grown from control and hTERT cells expressing the fusion protein pot1-TERT. The vessels from multiple donors (21). For hTERT vessels and for grown from these pot1-TERT cells may offer improved control vessels, we have found a correlation between infunctional performance as aortic interpositional grafts in creasing donor age and decreasing collagen content (and the nude rat, compared to control vessels. Pot1-TERT vessel mechanics), and also have observed a relative invessels demonstrate more proliferating nuclei than concrease of collagen content conferred by hTERT, within trol vessels, but also more apoptotic nuclei, indicating specific donors.
higher cell turnover rates. These preliminary findings inVessels engineered using pot1-TERT SMC contained dicate that transient delivery of telomerase, via the fuapproximately double the amount of collagen compared sion protein pot1-TERT, can allow the growth of imto control vessels. This is a promising finding, as collaproved engineered vessels in a manner that may avoid gen is the principal extracellular matrix component rethe safety concerns of long-term telomerase expression. sponsible for vessel strength (2, 22). This correlates with
